Earnings Per Share, Basic of ALPINE IMMUNE SCIENCES, INC. from 30 Sep 2016 to 31 Mar 2024
- Taxonomy & unit
- us-gaap: USD/shares
- Description
- The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
- Summary
-
ALPINE IMMUNE SCIENCES, INC. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 30 Sep 2016 to 31 Mar 2024.
- ALPINE IMMUNE SCIENCES, INC. Earnings Per Share, Basic for the quarter ending 31 Mar 2024 was -0.28, unchanged year-over-year.
- ALPINE IMMUNE SCIENCES, INC. Earnings Per Share, Basic for the twelve months ending 31 Mar 2024 was -1, a 64% increase year-over-year.
- ALPINE IMMUNE SCIENCES, INC. annual Earnings Per Share, Basic for 2023 was -0.64, a 63% increase from 2022.
- ALPINE IMMUNE SCIENCES, INC. annual Earnings Per Share, Basic for 2022 was -1.73, a 13% increase from 2021.
- ALPINE IMMUNE SCIENCES, INC. annual Earnings Per Share, Basic for 2021 was -1.98, a 48% decline from 2020.
- Source SEC data
- View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)
ALPINE IMMUNE SCIENCES, INC. Quarterly Earnings Per Share, Basic (USD/shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2024 | -1 | -0.28 | 0 | 0% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 09 May 2024 | 2024 | Q1 |
| Q4 2023 | -1 | 0.15 | +0.61 | 01 Oct 2023 | 31 Dec 2023 | 10-K | 20 Mar 2024 | 2023 | FY | |
| Q3 2023 | -1 | -0.24 | +0.18 | +43% | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 14 Nov 2023 | 2023 | Q3 |
| Q2 2023 | -1 | -0.27 | +0.33 | +55% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 14 Aug 2023 | 2023 | Q2 |
| Q1 2023 | -2 | -0.28 | -0.03 | -12% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 09 May 2024 | 2024 | Q1 |
| Q4 2022 | -2 | -0.46 | +0.06 | +12% | 01 Oct 2022 | 31 Dec 2022 | 10-K | 20 Mar 2024 | 2023 | FY |
| Q3 2022 | -2 | -0.42 | +0.13 | +24% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 14 Nov 2023 | 2023 | Q3 |
| Q2 2022 | -2 | -0.6 | -0.14 | -30% | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 14 Aug 2023 | 2023 | Q2 |
| Q1 2022 | -2 | -0.25 | +0.2 | +44% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 11 May 2023 | 2023 | Q1 |
| Q4 2021 | -2 | -0.52 | 01 Oct 2021 | 31 Dec 2021 | 10-K | 20 Mar 2024 | 2023 | FY | ||
| Q3 2021 | -0.55 | -0.27 | -96% | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 14 Nov 2022 | 2022 | Q3 | |
| Q2 2021 | -0.46 | +0.07 | +13% | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 11 Aug 2022 | 2022 | Q2 | |
| Q1 2021 | -0.45 | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 12 May 2022 | 2022 | Q1 | |||
| Q3 2020 | -0.28 | 01 Jul 2020 | 30 Sep 2020 | 10-Q | 10 Nov 2021 | 2021 | Q3 | |||
| Q2 2020 | -0.53 | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 10 Aug 2021 | 2021 | Q2 | |||
| Q3 2018 | -0.88 | -1.08 | -540% | 01 Jul 2018 | 30 Sep 2018 | 10-Q | 08 Nov 2018 | 2018 | Q3 | |
| Q3 2017 | 0.2 | +0.81 | 01 Jul 2017 | 30 Sep 2017 | 10-Q | 08 Nov 2018 | 2018 | Q3 | ||
| Q3 2016 | -0.61 | 01 Jul 2016 | 30 Sep 2016 | 10-Q | 14 Nov 2017 | 2017 | Q3 |
ALPINE IMMUNE SCIENCES, INC. Annual Earnings Per Share, Basic (USD/shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2023 | -0.64 | +1.09 | +63% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 20 Mar 2024 | 2023 | FY |
| 2022 | -1.73 | +0.25 | +13% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 20 Mar 2024 | 2023 | FY |
| 2021 | -1.98 | -0.64 | -48% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 20 Mar 2024 | 2023 | FY |
| 2020 | -1.34 | +0.94 | +41% | 01 Jan 2020 | 31 Dec 2020 | 10-K | 23 Mar 2023 | 2022 | FY |
| 2019 | -2.28 | 01 Jan 2019 | 31 Dec 2019 | 10-K | 17 Mar 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.